4.8 Article

Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

KLF4 is a key determinant in the development and progression of cerebral cavernous malformations

Roberto Cuttano et al.

EMBO MOLECULAR MEDICINE (2016)

Article Medicine, Research & Experimental

Defective autophagy is a key feature of cerebral cavernous malformations

Saverio Marchi et al.

EMBO MOLECULAR MEDICINE (2015)

Article Multidisciplinary Sciences

Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice

Luca Bravi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Multidisciplinary Sciences

Structure and vascular function of MEKK3-cerebral cavernous malformations 2 complex

Oriana S. Fisher et al.

NATURE COMMUNICATIONS (2015)

Article Cardiac & Cardiovascular Systems

Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation

Christopher C. Gibson et al.

CIRCULATION (2015)

Article Biochemistry & Molecular Biology

Lack of CCM1 induces hypersprouting and impairs response to flow

Tara M. Mleynek et al.

HUMAN MOLECULAR GENETICS (2014)

Article Multidisciplinary Sciences

EndMT contributes to the onset and progression of cerebral cavernous malformations

Luigi Maddaluno et al.

NATURE (2013)

Article Clinical Neurology

Cerebral cavernous malformations: from genes to proteins to disease Clinical article

Daniel D. Cavalcanti et al.

JOURNAL OF NEUROSURGERY (2012)

Article Immunology

Developmental timing of CCM2 loss influences cerebral cavernous malformations in mice

Gwenola Boulday et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2011)

Article Developmental Biology

A sensitive and bright single-cell resolution live imaging reporter of Wnt/β-catenin signaling in the mouse

Anna Ferrer-Vaquer et al.

BMC DEVELOPMENTAL BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Rho Kinase Inhibition Rescues the Endothelial Cell Cerebral Cavernous Malformation Phenotype

Asya L. Borikova et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Immunology

Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity

Rebecca A. Stockton et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2010)

Article Multidisciplinary Sciences

Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis

Yingdi Wang et al.

NATURE (2010)

Article Multidisciplinary Sciences

Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling

Joycelyn Wuestehube et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases

Kevin J. Whitehead et al.

NATURE MEDICINE (2009)

Article Cell Biology

KRIT-1/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions

Angela Glading et al.

JOURNAL OF CELL BIOLOGY (2007)

Article Cell Biology

KIf2 is an essential regulator of vascular hemodynamic forces in vivo

John S. Lee et al.

DEVELOPMENTAL CELL (2006)

Article Biochemistry & Molecular Biology

CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis

JS Zawistowski et al.

HUMAN MOLECULAR GENETICS (2005)

Letter Cell Biology

Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock

MT Uhlik et al.

NATURE CELL BIOLOGY (2003)

Article Developmental Biology

Tie2-Cre transgenic mice:: A new model for endothelial cell-lineage analysis in vivo

YY Kisanuki et al.

DEVELOPMENTAL BIOLOGY (2001)